Perrigo Co (BSP:P1RG34) Change In Receivables : R$-342 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Perrigo Co Change In Receivables?

Perrigo Co's change in receivables for the quarter that ended in Mar. 2024 was R$-258 Mil. It means Perrigo Co's Accounts Receivable increased by R$258 Mil from Dec. 2023 to Mar. 2024 .

Perrigo Co's change in receivables for the fiscal year that ended in Dec. 2023 was R$-280 Mil. It means Perrigo Co's Accounts Receivable increased by R$280 Mil from Dec. 2022 to Dec. 2023 .

Perrigo Co's Accounts Receivable for the quarter that ended in Mar. 2024 was R$3,884 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Perrigo Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 65.77.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Perrigo Co's liquidation value for the three months ended in Mar. 2024 was R$-20,697 Mil.

Perrigo Co Change In Receivables Historical Data

The historical data trend for Perrigo Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Change In Receivables Chart

Perrigo Co Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-577.50

868.94

-903.09

0.53

-279.78

Perrigo Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-207.30	-158.72	9.38	66.15	-258.45

Perrigo Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-342 Mil.

Perrigo Co (BSP:P1RG34) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Perrigo Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3884.244	/	5388.642	*	91
=	65.77

2. In Ben Graham's calculation of liquidation value, Perrigo Co's accounts receivable are only considered to be worth 75% of book value:

Perrigo Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3244.34	-	29646.243	+	0.75 * 3884.244	+	0.5 * 5583.85
=	-20,697

Perrigo Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Perrigo Co (BSP:P1RG34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (BSP:P1RG34) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

PRGO:USA PIG:Germany

Address

The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74

Website

https://www.perrigo.com

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (BSP:P1RG34) Headlines

No Headlines